UBS Group
OCEAW

UBS Group’s Ocean Biomediacal, Inc. Warrants OCEAW Stock Holding History

UBS Group’s Portfolio OCEAW Stock Details OCEAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,338
Closed -$683 – 10262
2024
Q1 		$683 Buy
+2,338
New +$341 ﹤0.01% 8415
2023
Q4 		– Sell
-781
Closed -$118 – 10038
2023
Q3 		$118 Buy
+781
New +$161 ﹤0.01% 8846
2023
Q2 		– Sell
-902
Closed -$253 – 9820
2023
Q1 		$253 Buy
+902
New +$194 ﹤0.01% 9119
2022
Q4 		– Sell
-1,999
Closed – – 11251
2022
Q3 		$0 Hold
1,999
– – ﹤0.01% 11065
2022
Q2 		$0 Buy
1,999
+400
+25% +$88 ﹤0.01% 11086
2022
Q1 		$0 Hold
1,599
– – ﹤0.01% 11036
2021
Q4 		$1K Buy
+1,599
New +$801 ﹤0.01% 10052

Other funds holding OCEAW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
CSD
Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

UBS Group's OCEAW Position: Q2 2024 in Review

UBS Group sold out of Ocean Biomediacal, Inc. Warrants (OCEAW) in Q2 2024, closing a stake of 2,338 shares — an estimated $683 sold.

UBS Group first reported a position in OCEAW in Q4 2021 and held it in 7 quarters. The position peaked at $1K in Q4 2021. 17 funds tracked by Wall St. Rank hold OCEAW as of Q2 2024.

  • UBS Group reported no remaining Ocean Biomediacal, Inc. Warrants position as of Q2 2024 after selling out during the quarter.
  • UBS Group sold 2,338 Ocean Biomediacal, Inc. Warrants shares in Q2 2024, an estimated $683.
  • UBS Group first reported a position in Ocean Biomediacal, Inc. Warrants in Q4 2021 and held it in 7 quarters.
  • UBS Group's Ocean Biomediacal, Inc. Warrants position peaked at $1K in Q4 2021.
  • 17 funds tracked by Wall St. Rank held Ocean Biomediacal, Inc. Warrants as of Q2 2024.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.